Skip to content

Clinical trials

Phase 2 Recurrence trials in Switzerland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Recurrence Phase: Phase 2 Country / region: Switzerland Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20061
20072
20132
20141
20161
20182
20201
20222
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Terminated4
Not yet recruiting1
Recruiting1
Suspended1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals3
Children's Oncology Group2
Celgene1
Centre Hospitalier Universitaire Vaudois1
Clovis Oncology, Inc.1
Eisai Inc.1
Genzyme, a Sanofi Company1
GlaxoSmithKline1
Kite, A Gilead Company1
Transgene1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Recurrence16
Lymphoma3
Burkitt Lymphoma2
Glioblastoma2
Lymphoma, Large B-Cell, Diffuse2
Neoplasm Metastasis2
Squamous Cell Carcinoma of Head and Neck2
Carcinoma1
Carcinoma, Non-Small-Cell Lung1
Dendritic Cell Sarcoma, Interdigitating1

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.